AMLo Biosciences

AMLo Biosciences

Formed in late 2017, AMLo Biosciences is dedicated to providing a prognostic test for early AJCC Stage I and Stage II melanoma to better identify patients’ true risk of disease progression. Those patients who are genuinely at low-risk of disease spread can be provided reassurance and better-informed follow-up care, while those identified at risk of metastasis are enabled to receive timely treatment.

Send an enquiry

By submitting this form, you consent to CPD sending you email regarding your application.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

AMLo Biosciences
AMLo Biosciences Office 9, The Biosphere, Drayman's Way, Newcastle Helix Newcastle upon Tyne NE4 5BX United Kingdom
Get directions

CPD Subsectors

Medical
Scientific Research
Health & Wellbeing
Patient Care